How Much Do You Know About CLL Prognosis and Management? Question Title * 1. Please indicate your degree: MD/DO PhD NP PA PharmD/RPh RN/BSN/MSN Other: Please Indicate Question Title * 2. Please indicate your primary specialty: Oncology Hematology-oncology Family Medicine/General Practice Internal Medicine Nursing Pharmacy Other: Please Indicate Question Title * 3. Approximately how many patients with CLL do you see or manage per month? 1 to 2 3 to 5 6 to 10 More than 10 N/A Question Title * 4. What is your practice setting? Academic Community Question Title * 5. When do you undertake mutational testing in your patients with CLL? At diagnosis At disease relapse At diagnosis and relapse I do not use mutational testing Question Title * 6. How confident are you selecting treatment based upon risk stratification for your newly diagnosed patients with CLL? Very confident Confident Somewhat confident Not confident Question Title * 7. What treatment would you select for a newly diagnosed patient younger than 70 years old with 17p deletion? FCR BR Ibrutinib Idelalisib + rituximab Venetoclax Unsure Question Title * 8. How confident are you in selecting treatment for your patients with relapsed or refractory CLL? Very confident Confident Somewhat confident Not confident Question Title * 9. What treatment would you select for a patient younger than 70 years old with 17p deletion who has relapsed after ibrutinib treatment? FCR BR Continue ibrutinib Idelalisib + rituximab Venetoclax Unsure Question Title * 10. Which of the following strategies can help reduce the risk of tumor lysis syndrome in patients receiving venetoclax? Use in combination with rituximab Up titration to desired dose over a 5-week period Avoid use in patients over 70 years of age Avoid use in patients who relapsed on idelalisib treatment Question Title * 11. How do you prefer to receive continuing education (CME/CPE/CNE/AANP/AAPA/Other) credits? (Select one) Live meetings/courses Live online webinars that you can participate in Online web activities Print materials Other (Please List) Question Title * 12. Which of the following formats do you prefer to best facilitate learning in CME activities? Didactic lectures Small group workshops Clinical case presentations or simulations Gamified modules “Micro CME” (10-15 min per activity) Other (please specify) Question Title * 13. Please provide any additional suggestions regarding topics of interest and formats for education below: Submit